Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

50%

4 of 8 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A

6(75.0%)

Phase 3

1(12.5%)

Phase 4

1(12.5%)

8Total

N/A(6)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05936996Completed

Prospective Clinical Registry Evaluating Contemporary MANTA Outcomes

Role: collaborator

NCT04862689Not ApplicableCompleted

Investigation of the Ringer Perfusion Balloon Catheter (Ringer PTCA)

Role: lead

NCT04849169Not ApplicableCompleted

Investigation of the Ringer Perfusion Balloon Catheter

Role: lead

NCT03988166Not ApplicableCompleted

Chronic Total Occlusion Percutaneous Coronary Intervention Study

Role: lead

NCT03072446Not ApplicableCompleted

Uterine Fibroid Embolization (UFE) for Symptomatic Fibroids: Comparison of Gel-Bead to Commonly Used Embolic Agents.

Role: collaborator

NCT00652314Phase 4Completed

Evaluation of an Absorbable Surgical Hemostatic Agent: Thrombi-Gel® Versus Gelfoam-Thrombin

Role: lead

NCT00565604Not ApplicableCompleted

Safety and Efficacy of Endovenous Laser Ablation for the Resolution of Incompetent Perforator Veins

Role: lead

NCT00388284Phase 3Completed

Safety and Efficacy Study Comparing Thrombin for Arterial Sealing

Role: lead

NCT00618514Not ApplicableTerminated

The BRILLIANT Study

Role: lead

All 9 trials loaded